Design, Synthesis and Biological Evaluation of Pazopanib Derivatives as Antitumor Agents

被引：51

作者：

Jia, Yuping ^{[1
]}

Zhang, Jian ^{[2
]}

Feng, Jinhong ^{[3
]}

Xu, Fuming ^{[2
]}

Pan, Huili ^{[2
]}

Xu, Wenfang ^{[2
]}

机构：

[1] Shandong Inst Pharmaceut Ind, Jinan 250101, Shandong, Peoples R China

[2] Shandong Univ, Dept Med Chem, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China

[3] Shandong Acad Sci, Shandong Anal & Test Ctr, Jinan 250012, Shandong, Peoples R China

来源：

CHEMICAL BIOLOGY & DRUG DESIGN | 2014年 / 83卷 / 03期

基金：

国家高技术研究发展计划(863计划); 中国国家自然科学基金;

关键词：

anti-angiogenesis; antitumor agent; pazopanib derivatives; synthesis; ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; INHIBITORS; MECHANISMS; THERAPY; KINASES; TARGET; CELLS;

D O I：

10.1111/cbdd.12243

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A novel series of pazopanib derivatives were designed, synthesized, and evaluated for their inhibitory activity against a series of kinases including VEGFR-2, EGFR, AKT1, ALK1, and ABL1. The anti-angiogenic activities ex vivo of some compounds were also investigated. Compounds P2d and P2e demonstrated outstanding inhibitory activity against VEGFR-2 and ABL1 and higher anti-angiogenic activity compared with Pazopanib, the reference standard. These two compounds (P2d and P2e) could be used as novel lead compounds for further development of anticancer agents.

引用

下载

页码：306 / 316

页数：11

共 50 条

[1] Synthesis and biological evaluation of novel pazopanib derivatives as antitumor agents
Qi, Haofei
Chen, Ligong
Liu, Bingni
Wang, Xinran
Long, Li
Liu, Dengke
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (04) : 1108 - 1110
[2] Design, synthesis and biological evaluation of valepotriate derivatives as novel antitumor agents
Zhang, Bo
Guo, Ruiying
Hu, Yongzhou
Dong, Xiaowu
Lin, Nengming
Dai, Xiaoyang
Wu, Honghai
Ma, Shenglin
Yang, Bo
RSC ADVANCES, 2017, 7 (51): : 31899 - 31906
[3] Design, synthesis and biological evaluation of phenylpicolinamide sorafenib derivatives as antitumor agents
Chunjiang Wu
Shan Xu
Yuping Guo
Jielian Wu
Rong Luo
Wenhui Wang
Yuanbiao Tu
Wufu Le Chen
Pengwu Zhu
Medicinal Chemistry Research, 2018, 27 : 374 - 387
[4] Design, synthesis and biological evaluation of piperine derivatives as potent antitumor agents
Wang, Xiu-Jun
Qiao, Yue
Wang, Xiao-Shuo
Zhang, Si-Yi
Li, Han-Xue
Hao, Hui-Hui
Li, Kuang-qi
Ma, Shao-Jie
Zhu, Qi-jun
Ji, Jing
Liu, Bin
FITOTERAPIA, 2024, 177
[5] Design, synthesis and biological evaluation of phenylpicolinamide sorafenib derivatives as antitumor agents
Wu, Chunjiang
Xu, Shan
Guo, Yuping
Wu, Jielian
Luo, Rong
Wang, Wenhui
Tu, Yuanbiao
Chen, Le
Zhu, Wufu
Zheng, Pengwu
MEDICINAL CHEMISTRY RESEARCH, 2018, 27 (02) : 374 - 387
[6] Design, synthesis and biological evaluation of flavonoid salicylate derivatives as potential antitumor agents
Deng, Xiangping
Wang, Zhe
Liu, Juan
Xiong, Shujuan
Xiong, Runde
Cao, Xuan
Chen, Yanming
Zheng, Xing
Tang, Guotao
RSC ADVANCES, 2017, 7 (61): : 38171 - 38178
[7] Design, synthesis, and biological evaluation of biotinylated colchicine derivatives as potential antitumor agents
Wang, Chao
Zhang, Yujing
Wang, Zeyu
Li, Yuelin
Guan, Qi
Xing, Dongming
Zhang, Weige
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 411 - 420
[8] Design, synthesis, and biological evaluation of novel Tempol derivatives as effective antitumor agents
Sun, Xiao-Liang
Wang, Shi-Yu
Qi, Zhi-Min
Wan, Ning
Zhang, Bang-Le
He, Wei
RESEARCH ON CHEMICAL INTERMEDIATES, 2016, 42 (10) : 7659 - 7673
[9] Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents
Su, Tong
Zhu, Jiongchang
Sun, Rongqin
Zhang, Huihui
Huang, Qiuhua
Zhang, Xiaodong
Du, Runlei
Qiu, Liqin
Cao, Rihui
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 178 : 154 - 167
[10] Design, synthesis, and biological evaluation of novel Tempol derivatives as effective antitumor agents
Xiao-Liang Sun
Shi-Yu Wang
Zhi-Min Qi
Ning Wan
Bang-Le Zhang
Wei He
Research on Chemical Intermediates, 2016, 42 : 7659 - 7673

← 1 2 3 4 5 →